MATERNA - TAB 25 MCG
MOLYBDENUM (SODIUM MOLYBDATE) : 25 MCG MANGANESE (MANGANESE SULFATE) : 5 MG IODINE (POTASSIUM IODIDE) : .15 MG D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE) : 10 MG CALCIUM (CALCIUM CARBONATE) : 250 MG CHROMIUM (CHROMIC CHLORIDE) : 25 MCG IRON (FERROUS FUMARATE) : 60 MG PYRIDOXINE HYDROCHLORIDE : 10 MG BIOTIN : 30 MCG ASCORBIC ACID : 100 MG NICOTINAMIDE : 20 MG THIAMINE MONONITRATE : 3 MG VITAMIN B12 : 12 MCG BETA-CAROTENE : 1500 UNIT VITAMIN B2 : 3.4 MG VITAMIN D3 : 250 UNIT DL-ALPHA TOCOPHERYL ACETATE : 30 UNIT VITAMIN A ACETATE : 1500 UNIT FOLIC ACID : 1 MG ZINC (ZINC OXIDE) : 25 MG COPPER (CUPRIC OXIDE) : 2 MG MAGNESIUM (MAGNESIUM OXIDE) : 50 MG · DIN 02170043 · WYETH-AYERST CANADA INC.
Health Canada status: CANCELLED POST MARKET
What is MATERNA - TAB?
MATERNA - TAB 25 MCG contains MOLYBDENUM (SODIUM MOLYBDATE) : 25 MCG MANGANESE (MANGANESE SULFATE) : 5 MG IODINE (POTASSIUM IODIDE) : .15 MG D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE) : 10 MG CALCIUM (CALCIUM CARBONATE) : 250 MG CHROMIUM (CHROMIC CHLORIDE) : 25 MCG IRON (FERROUS FUMARATE) : 60 MG PYRIDOXINE HYDROCHLORIDE : 10 MG BIOTIN : 30 MCG ASCORBIC ACID : 100 MG NICOTINAMIDE : 20 MG THIAMINE MONONITRATE : 3 MG VITAMIN B12 : 12 MCG BETA-CAROTENE : 1500 UNIT VITAMIN B2 : 3.4 MG VITAMIN D3 : 250 UNIT DL-ALPHA TOCOPHERYL ACETATE : 30 UNIT VITAMIN A ACETATE : 1500 UNIT FOLIC ACID : 1 MG ZINC (ZINC OXIDE) : 25 MG COPPER (CUPRIC OXIDE) : 2 MG MAGNESIUM (MAGNESIUM OXIDE) : 50 MG. It is listed in the Health Canada Drug Product Database under DIN 02170043, held by WYETH-AYERST CANADA INC., supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 03-Aug-2001. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02170043 |
|---|---|
| Brand name | MATERNA - TAB |
| Generic / active ingredient | MOLYBDENUM (SODIUM MOLYBDATE) : 25 MCG MANGANESE (MANGANESE SULFATE) : 5 MG IODINE (POTASSIUM IODIDE) : .15 MG D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE) : 10 MG CALCIUM (CALCIUM CARBONATE) : 250 MG CHROMIUM (CHROMIC CHLORIDE) : 25 MCG IRON (FERROUS FUMARATE) : 60 MG PYRIDOXINE HYDROCHLORIDE : 10 MG BIOTIN : 30 MCG ASCORBIC ACID : 100 MG NICOTINAMIDE : 20 MG THIAMINE MONONITRATE : 3 MG VITAMIN B12 : 12 MCG BETA-CAROTENE : 1500 UNIT VITAMIN B2 : 3.4 MG VITAMIN D3 : 250 UNIT DL-ALPHA TOCOPHERYL ACETATE : 30 UNIT VITAMIN A ACETATE : 1500 UNIT FOLIC ACID : 1 MG ZINC (ZINC OXIDE) : 25 MG COPPER (CUPRIC OXIDE) : 2 MG MAGNESIUM (MAGNESIUM OXIDE) : 50 MG |
| Manufacturer | WYETH-AYERST CANADA INC. |
| Strength | 25 MCG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | B03AE04 IRON, MULTIVITAMINS AND MINERALS |
| AHFS class | 08:16.04 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 03-Aug-2001 |
| Original market date | 1996-11-15 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code B03AE04 IRON, MULTIVITAMINS AND MINERALS. 2 of 26 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| PREGVIT | 2 MG | TABLET | DUCHESNAY INC | MARKETED | DIN 02552620 |
| PREGVIT FOLIC 5 | 3.4 MG | TABLET | DUCHESNAY INC | MARKETED | DIN 02552639 |
| GESTAMINE COMPRIMES | 60 MG | TABLET | LAB NADEAU LTÉE, DIVISION OF TECHNILAB INC. | CANCELLED POST MARKET | DIN 00722227 |
| IRON PLUS MANGANESE, B12, FOLIC ACID & C | 10 MCG | TABLET | NATURAL FACTORS NUTRITIONAL PRODUCTS LTD. | CANCELLED POST MARKET | DIN 00770760 |
| MATERNA TAB | 60 MG | TABLET | CYANAMID CANADA INC. | CANCELLED POST MARKET | DIN 01900587 |
| MATERNA-TAB | .15 MG | TABLET | LEDERLE CONSUMER HEALTH PRODUCTS | CANCELLED POST MARKET | DIN 02131277 |
| MATERNITY ONE MULTIVITAMIN WITH MINS CAPLET | 60 MG | TABLET | SWISS HERBAL REMEDIES LTD. | CANCELLED POST MARKET | DIN 01918052 |
| NUTRIFER PLUS TAB | 150 MG | TABLET | WHITEHALL-ROBINS INC. | CANCELLED POST MARKET | DIN 01932683 |
| ORIFER F | 20 MG | TABLET | SANOFI-AVENTIS CANADA INC | CANCELLED POST MARKET | DIN 02103044 |
| PREGNANCY MULTIVITAMIN | 12 MCG | TABLET | JAMP PHARMA CORPORATION | DORMANT | DIN 02535718 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.